Live from the NIH registry
Studies recruiting near Greensboro right now
Top 25 of 596 recruiting studies, sorted by proximity — each links to its official registry page
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
N/A
Observational 20,000 participants sought
Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Wake Forest University Health Sciences
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cone Health Cancer Center — Greensboro, North Carolina (2.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: National Cancer Institute (NCI)
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
N/A
Interventional 286 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Wake Forest University Health Sciences
A Mobile Intervention to Reduce Pain and Improve Health-III
Chronic Pain, Osteoarthritis
Phase 2
Interventional 200 participants sought
Wake Forest University — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Wake Forest University
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (2.5 mi)
· Sponsor: AbbVie
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
N/A
Interventional 55 participants sought
Lyndhurst Clinical Research — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Coologics, Inc
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Cone Health Cancer Center — Greensboro, North Carolina (2.5 mi)
· Sponsor: NRG Oncology
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Asheboro, North Carolina (26.8 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
Depression, Cancer
N/A
Interventional 208 participants sought
Wake Forest University — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: East Carolina University
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Giselle Sholler
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Cone Health — Greensboro, North Carolina (2.5 mi)
· Sponsor: Analog Device, Inc.
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Novartis Pharmaceuticals
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: AstraZeneca
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
Phase 2
Interventional 48 participants sought
3203, Greensboro CRS — Greensboro, North Carolina (2.5 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
Atrium Health Wake Forest Baptist Medical Center — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Yale University
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Atrium Health Wake Forest Baptist (Wake Forest Baptist) — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Jaeb Center for Health Research
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Atrium Health Wake Forest Baptist — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Nicole Hamblett
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Wake Forest University - School of Medicine - Central — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Takeda
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3
Interventional 59 participants sought
Atrium Health Wake Forest Baptist — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Takeda
Dyad Plus Effectiveness/Feasibility
Weight Loss, Pediatric Obesity
N/A
Interventional 90 participants sought
Wake Forest Baptist Medical Center — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Wake Forest University Health Sciences
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
Wake Forest University Baptist Medical Center ( WFUBMC ) — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Pfizer
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Wake Forest University Health Sciences — High Point, North Carolina (13.9 mi)
· Sponsor: Duke University
Evaluation of Flexible Conductive Hearing Aids
Conductive Hearing Loss
N/A
Interventional 200 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Wake Forest University Health Sciences
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
Pancreas Adenocarcinoma, Cachexia
N/A
Observational 100 participants sought
Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (23.3 mi)
· Sponsor: Wake Forest University Health Sciences